Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
cancer
6
×
life sciences
national blog main
national top stories
roche
6
×
san francisco blog main
san francisco top stories
biotech
indiana blog main
indiana top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
investing
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
deals
novartis
president trump
sanofi
alexion pharmaceuticals
amgen
blueprint medicines
cancer drugs
cancer immunotherapy
What
drug
6
×
cancer
roundup
bio
fda
genetic
latest
medicines
new
plan
targets
address
advantages
ahead
alzheimer’s
ambien
american
annual
approval
approved
approves
asco
attendees
attention
bar
biotech
blueprint
brings
camp’s
carries
cash
certain
chicago
city
clinical
combinations
community’s
companies
days
deeper
Language
unset
Current search:
roche
×
drug
×
cancer
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More